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Abstract
Background: The aim of the study was to find a simple intravenous glucose
tolerance test (IVGTT) that can be used to estimate insulin sensitivity.
Methods: In 20 healthy volunteers aged between 18 and 51 years (mean, 28)
comparisons were made between kinetic parameters derived from a 12-sample, 75-
min IVGTT and the Mbw (glucose uptake) obtained during a hyperinsulinemic
euglycemic glucose clamp. Plasma glucose was used to calculate the volume of
distribution (Vd) and the clearance (CL) of the injected glucose bolus. The plasma
insulin response was quantified by the area under the curve (AUCins). Uptake of
glucose during the clamp was corrected for body weight (Mbw).
Results: There was a 7-fold variation in Mbw. Algorithms based on the slope of the
glucose-elimination curve (CL/Vd) in combination with AUCins obtained during the
IVGTT showed statistically significant correlations with Mbw, the linearity being r
2 =
0.63-0.83. The best algorithms were associated with a 25-75th prediction error
ranging from -10% to +10%. Sampling could be shortened to 30-40 min without loss
of linearity or precision.
Conclusion: Simple measures of glucose and insulin kinetics during an IVGTT can
predict between 2/3 and 4/5 of the insulin sensitivity.
Introduction
The best established methods of measuring insulin resistance are the hyperinsulinemic
euglycemic glucose clamp and the intravenous glucose tolerance test (IVGTT), of
which former is the “gold standard” [1-3]. These methods have a long history as inves-
tigative tools in diabetes research but are too cumbersome to be used during surgery,
although insulin resistance develops in this setting [4,5].
The aim of this project is to evaluate a simplified IVGTT test that lasts for 30, 40 or
75 min. This test is less labour-intensive than both the glucose clamp and the conven-
tional IVGTT. Analysis of the data is based on a comparison between the “strength” of
the insulin response and the elimination kinetics of glucose. A commonly used expres-
sion for the “strength” of a physiological factor is the area under the curve (AUC),
which was applied here on insulin, while the slope of the elimination curve for glucose
served to quantify the “effect”.
The hypothesis was that the test could predict insulin resistance with the same or
higher precision than the “minimal model” (MINMOD) which is typically based on a
longer IVGTT and quite demanding mathematically [6,7]. We assessed this objective
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by comparing the simplified IVGTT with the result of the glucose clamp in 20 healthy
volunteers.
Materials and methods
Twenty non-obese healthy volunteers, 8 females and 12 males, aged between 18 and 51
(mean, 28) years and with a body weight of 49-88 (mean, 68) kg, were studied. None of
them had any disease requiring medication, and routine blood chemistry confirmed the
absence of metabolic disease (Table 1, top). The study was approved by the Regional
Ethics Committee in Stockholm and complied with the Helsinki Declaration. Each
volunteer gave his/her written consent to participate.
Euglycemic hyperinsulinemic clamp
The subjects reported at the laboratory between 7.30-8.00 AM. A superficial dorsal
hand vein was cannulated in retrograde direction with a small three-way needle and
kept patent by repeated flushing with saline solution. The hand and lower arm were
warmed by a heating pad for intermittent sampling of arterialized venous blood for
glucose determination (Hemocue, Ängelholm, Sweden). In the opposite arm an intra-
venous catheter was inserted into the left antecubital vein for insulin and glucose
infusion.
During the 120-min test, insulin 20 mU · BSA m-2 · min-1 (Human Actrapid, Novo-
Nordisk A/S, Bagsverd, Denmark) was infused along with 20% dextrose (Fresenius
Kabi, Uppsala, Sweden). Baseline blood samples were drawn and the euglycemic
Table 1 Baseline data and key results for the IVGTT and the glucose clamp.
Parameter Mean (SD), or median
(25th-75th percentiles)
Unit
Health status
Body mass index 23.4 (2.3) kg/m2
HbA1c 44 (0.5) mmol/mol
Blood Hb concentration 126 (14) mmol/L;
Serum creatinine concentration 83 (3) μmol/L
Serum sodium and potassium concentrations 141 (2); 3.9 (0.3) mmol/L
IVGTT
Plasma glucose, baseline 4.8 (0.5) mmol L-1
Plasma insulin, baseline 21 (12-24) pmol L-1
Volume of distribution (Vd) 14.0 (6.5) L
per kg body weight 0.20 (0.09) L kg-1
Clearance (CL) 0.63 (0.26) L min-1
per kilo body weight 9.3 (3.8) ml min-1 kg-1
Insulin sensitivity (SI) of MINMOD 16 (7-32) 10
-5 L pmol-1 min-1
Glucose effectiveness (SG) in MINMOD 13 (5-26) 10
-3 min-1
Glucose clamp
Plasma glucose, baseline 5.0 (1.0) mmol L-1
Plasma insulin, baseline 16 (7-30) pmol L-1
Plasma glucose, mean 90-120 min 5.7 (0.3) mmol L-1
Plasma insulin, mean 90-120 min 167 (34) pmol L-1
Glucose metabolism, M, 90-120 min 3.1 (1.2) mmol min-1
Mbw = per kg body weight 45 (15) μmol min
-1 kg-1
IVGTT = intravenous glucose tolerance test
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hyperinsulinemic clamp was initiated by infusion of a bolus dose of insulin for 4 min-
utes followed by a step-wise increase in glucose for 10 min. The glucose infusion rate
was adjusted to keep the subjects’ blood glucose level constant at 5 mmol/L on the
basis of arterialized samples withdrawn every 5 min from the dorsal hand vein catheter
[8]. The infusion rate during the last 30 min, after correction for body weight, was
taken to represent the metabolism of glucose (Mbw) [1-3].
Intravenous glucose tolerance test
On the second occasion, 1-2 days apart from the clamp study and after 12 h of fasting,
a regular intravenous glucose tolerance test (IVGTT) was performed to determine the
early insulin response phase (0-10 min), as well as the area-under-the-curve for insulin
(AUCins being total insulin and ΔAUCins above baseline) and C-peptide for up to 75
minutes. A bolus of glucose (300 mg/kg in a 30% solution) was given within 60 sec
into the antecubital vein. Blood was sampled from the contralateral antecubital vein at
0, 2, 4, 6, 8, 10, 20, 30, 40, 50, 60 and 75 min for assessment of the plasma glucose,
insulin, and C-peptide concentrations. Plasma glucose was measured by the glucose
oxidase method used by the hospital’s routine laboratory. Plasma insulin and C-peptide
were measured using ELISA kits (Mercodia AB, Uppsala, Sweden).
Calculations
The pharmacokinetics of the glucose load was analysed using a one-compartment open
model [9]. Here, the plasma concentration (G) at any time (t) resulting from infusing
glucose at the rate Ro is calculated from the following differential equation:
d(G − Gb)
dt
=
Ro
Vd
− CL
Vd
∗ (G(t) − Gb)
where Gb is the baseline glucose, Vd is the volume of distribution, CL the clearance
and CL/Vd the slope of the glucose elimination curve. The half-life (T1/2) of the exo-
genous glucose load was obtained as (ln 2 Vd /CL). The AUC for plasma insulin was
calculated by using the linear trapezoid method.
The glucose and insulin data were also analyzed by applying the “minimal model”
(MINMOD) of Bergman et al. [6,7]. The kinetic system consists of two differential
equations:
dG
dt
= −G(t) ∗ [SG + X(t)] + Gb ∗ SG
dX
dt
= −p2 ∗ X(t) + p3 ∗ F(t), SI = p3p2
where SI = glucose sensitivity, SG = glucose effectiveness, X(t) is insulin action in the
interstitial fluid space, and F(t) a function for the elevation of plasma insulin above the
basal level. p2 is the removal rate of insulin from the interstitial fluid space while p3
describes the movement of circulating insulin to the interstitial space.
The best estimates for the unknown parameters in these models were estimated for
each of the 20 experiments individually by nonlinear least-squares regression. No
weights were used. The mathematical software was Matlab R2010a (MathWorks,
Natick, MA, USA).
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The insulin sensitivity was also quantified by “Quicki”, which is the inverse of the
logarithm of the product of plasma glucose and plasma insulin at baseline [10]. Finally,
we tested the recently proposed equation by Tura et al. [11] for short IVGTTs:
CS1 = 0.276
KG
AUCins/T
where CS1 a surrogate measure for insulin sensitivity, KG is the slope of the glucose
elimination curve (same as CL/Vd) and T is the time after 10 min.
Statistics
The results were presented as mean and standard deviation (SD) and, when there was
a skewed distribution, as the median (25th-75th percentile range). Simple or multiple
linear regression analysis, in which r2 is the coefficient of determination, was used to
express “linearity” when studying the relationship between the Mbw of the glucose
clamp (control) and various algorithms for insulin sensitivity derived from data col-
lected during the IVGTT. The error in the prediction of Mbw associated with each
regression analysis was obtained as [100% (fitted-measured)/measured]. The change in
prediction error obtained by restricting the analysis period from 75 to 40 and 30 min
was tested by Friedman’s test. All reported correlations were statistically significant by
P < 0.05.
Results
Clamp
Mbw of the glucose clamp varied 7-fold (Table 1, middle). Between 2/3 and 4/5 of this
variability could be predicted by linear regression based on indices of glucose and insu-
lin turnover obtained from the data collected during the IVGTT.
IVGTT
All 20 experiments could be analysed with the proposed equations for plasma glucose
and insulin kinetics (Figure 1; Table 1, bottom). However, the glucose kinetics of 3
experiments were studied only up to 40 min due to rapid elimination followed by mild
hypoglycemia, which otherwise distorted the elimination slope.
First key algorithm
One useful algorithm contained the 10log of the product of T1/2 for the exogenous glu-
cose load and AUC for plasma insulin. Various modifications of the algorithm corre-
lated with Mbw with a linearity of r
2 = 0.63-0.68 (Figure 2A, Table 2).
Consistently weaker correlations were obtained on correcting Mbw for the steady
state plasma glucose and insulin concentrations (data not shown, r2≈0.40-0.50).
This key algorithm has the same construction as “Quicki” which uses only the baseline
values of plasma glucose and insulin. The original “Quicki” equation correlated with Mbw
with a linearity of only r2 = 0.41 (Figure 2B) which was still slightly stronger than for other
similar expressions, such as HOMA-IR (r2 = 0.35) and the G/I ratio (r2 = 0.39) [2].
MINMOD and Tura’s equation
Weaker correlations were also obtained when comparing Mbw with the insulin sensitiv-
ity as obtained by “minimal model analysis” (MINMOD) of the IVGTT data (r2 = 0.34,
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Figure 2C). Plots of X(t) obtained by MINMOD indicated that the insulin concentra-
tion at the effect site was highest at 18 min (13-33) min.
The recently published equation by Tura et al. [11] correlated with Mbw with a line-
arity of r2 = 0.54 for the period 0-40 min. Logarithm-transformation of Tura’s surro-
gate measure for insulin sensitivity increased r2 to 0.65.
Figure 1 Plasma concentrations during the IVGTT. Plasma glucose above baseline (A) and the plasma
insulin (B) and C-peptide concentrations (C) during 20 intravenous glucose tolerance tests (IVGTTs). The
thin lines represent one experiment. The thick line in A is the modelled average curve, based on the
kinetic data shown in Table 1, while B and C are the mean for each point in time.
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Second key algorithm
Another equation applied the parameters of the glucose kinetics directly and might
therefore be easier to handle (Table 3, Figure 3A).
A promising modification of this second key algorithm inserted the parameters of the
glucose kinetics and the AUC for plasma insulin in a multiple regression equation,
which yielded a maximum linearity of r2 = 0.83 for the relationship between the
IVGTT and Mbw (Table 3, Figure 3B).
Slight strengthening of the linearity was always obtained by using AUCins without
correction for the baseline plasma insulin level (Tables 2 and 3).
Exploratory analyses
Replacing AUCins by the sum of the plasma insulin concentrations for various periods
of time did not greatly impair linearity or the prediction error (Table 3, Figure 3C).
The overall linear correlation between the AUC for C-peptide and insulin was r2 =
0.66. However, replacing AUCins by AUC for C-peptide in the equations proposed
above greatly reduce their linearity with Mbw (r
2 ≈ 0.20).
Figure 2 Insulin resistance as given by the glucose clamp and a short IVGTT. (A) The relationship
between Mbw of the hyperinsulinemic euglycemic clamp and a surrogate expression for insulin sensitivity
based on the half-life of glucose and the area under the curve (AUC) for plasma insulin during a 75-min
IVGTT in 20 volunteers. (B) Same equation but using only baseline plasma glucose and insulin
concentrations. (C) Mbw versus insulin sensitivity obtained by “minimal model” (MINMOD) analysis.
Table 2 Linear correlations between the IVGTT and the glucose clamp.
Y X Equation Time
period
r2 25th-75th percentiles
of prediction error
Mbw
[
1
10 log(T1/2 •AUCins)
]
Y = -172 + 1040 X 75 min 0.63 -10% +16%
Y = -201 + 1179 X 40 min 0.63 -8% +20%
Y = -219 + 1256 X 30 min 0.62 -12% +26%
Same equation, but using total insulin AUC Y = -220 + 1310 X 75 min 0.68 -11% +9%
Y = -218 + 1287 X 40 min 0.63 -8% +12%
Y = -248 + 1419 X 30 min 0.66 -8% +20%
Mbw
[
1
10 log(glucoseo*Inso)
]
Y = -19 +124 X Baseline
“Quicki”
0.41 -14% +11%
Mbw SI of MINMOD 10
-5 Y = 36 + 0.38 X 75 min 0.34 -16% +24%
Equations compare the cellular uptake of glucose obtained by the glucose clamp (Mbw,; μmol min
-1 kg-1) and indices of
glucose kinetics and plasma insulin obtained during an intravenous glucose tolerance test (IVGTT) in 20 non-obese
volunteers.
T1/2 = half-life of exogenous glucose (units: min)
Glucoseo, Inso = plasma concentrations of glucose and insulin at baseline (units: mmol L
-1 and pmol L-1)
AUCins = area under the curve for plasma insulin over time (unit: pmol min L
-1)
MINMOD = “minimal model analysis” according to Bergman et al. [6]
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Discussion
IVGTT versus the glucose clamp
The present study searched for an approach to estimate insulin sensitivity that requires
only minimum of resources. The results are presented as a number of regression equa-
tions that compare Mbw of the glucose clamp (control) with minor mathematical varia-
tions of two key algorithms based on data derived from a short IVGTT. Any of them
may be used as substitutes for a glucose clamp in healthy volunteers, although some
offer stronger linearity and a smaller prediction error than others.
The first of the key algorithms, shown on top of Table 2, is constructed in a way
similar to the “Quicki” [10]. However, the linearity was much stronger when based on
the IVGTT as compared to the baseline data used in the “Quicki” (Figure 2A, B).
Various modifications of the second key algorithm, presented in Table 3, were also
tested. A promising change was to consider the sum of the slope of the glucose
Table 3 Further linear correlations between the IVGTT and the glucose clamp.
Y X Equation Time
period
r2 25th-75th percentiles
of prediction error
Mbw 10 log
[
CL ∗ 106
Vd •AUCins
]
Y = -2.5 + 45.4 X 75 min 0.64 -10% +16%
Y = -8.6 + 51.5 X 40 min 0.64 -8% +21%
Y = -13.8 + 54.9 X 30 min 0.64 -12% +25%
Same equation, but using total
insulin AUC
Y = -2.8 + 53.4 X 75 min 0.68 -10% +9%
Y = -6.1 + 54.0 X 40 min 0.64 -8% +13%
Y = -14.5 + 60.0 X 30 min 0.67 -8% +20%
Mbw 10 log [AUCins] Y = 206 - 49.0 X + 340 CL/Vd 75 min 0.70 -11% +16%
Y = 224 - 56.4 X + 480 CL/Vd 40 min 0.74 -10% +20%
Y = 223 - 57.9 X + 580 CL/Vd 30 min 0.70 -10% +23%
Same equation, but using total
insulin AUC
Y = 265 - 63.6 X + 383 CL/Vd 75 min 0.83 -9% +11%
Y = 262 - 65.4 X + 488 CL/Vd 40 min 0.82 -10% +11%
Y = 260 - 67.1 X + 602 CL/Vd 30 min 0.79 -8% +14%
Mbw 10 log
[
CL ∗ 106
Vd • Insmean
]
Y = -99 + 54.0 X 75 min 0.63 -10% +16%
Y = -9 + 51.5 X 10-40 min 0.64 -8% +21%
Y = -14 + 54.9 X 10-30 min 0.64 -12% +26%
Vd, CL = volume of distribution and clearance of glucose for the IVGTT (units: L and L min
-1, respectively).
Insmean, = mean value plasma of insulin (units: pmol L
-1)
AUCins = area under the curve for plasma insulin over time (unit: pmol min L
-1)
Figure 3 Insulin resistance by the glucose clamp and a short IVGTT. The relationship between Mbw
and various combinations of the clearance (CL) and volume of distribution (Vd) of glucose and (A, B) the
area under the curve for plasma insulin (AUCins) during the 75-min IVGTT, or (C) using the mean plasma
insulin level measured at 10, 20, 30, and 40 min.
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elimination curve, CL/Vd, and the insulin “pressure”, AUCins, in a multiple regression
equation. This approach could explain up to 83% of the inter-individual variability in
Mbw (Figure 3).
Reducing the sampling time from 75 min to 40 min, or even 30 min, had only small
undue effects on our quality measures, i.e. the linearity and the prediction error.
Corrections for baseline concentrations
The relationship between plasma insulin and glucose is not a simple one. The dose-
response curve is hyperbolic (saturation kinetics) [2,3] and the CL of glucose is related
to the 10log of the insulin level [3,12].
The saturation kinetics makes it questionable to correct Mbw for the steady state
insulin level in plasma to yield the Mbw/I ratio, although this is often done. The high
concentration of insulin at the effect site at the end of a glucose clamp probably
changes CL very little for a large increment in plasma insulin. Correcting Mbw for
steady state plasma insulin also resulted in poorer correlations vis-à-vis the IVGTT.
Likewise, one may question whether baseline insulin should be subtracted from
AUCins when estimating Mbw from an IVGTT test. Although being a logical and com-
monly used correction, disregarding the baseline strengthened the correlations in the
present study. Inhibition of the endogenous glucose production taking place early dur-
ing the IVGTT is likely to make the insulin concentration below baseline govern the
disposition of both the exogenous and the endogenous glucose later during the test.
Differences in the mathematical correlations between the glucose clamp and the
IVGTT were fairly small, however, and we therefore conclude that correcting for base-
line insulin can be done, but is not essential.
Comparison with other methods
The precision by which our 12-sample IVGTT could predict insulin sensitivity stands
out favourably in comparison with other and more complex approaches, as presented
in a review by Borai et al. [1].
A previous study of MINMOD based on a series of 25 blood samples showed a line-
arity to the glucose clamp that was quite similar to the r2 = 0.34 found here [13]. The
new algorithms thus offered far better linearity than MINMOD in the present setting.
MINMOD contains four unknown parameters that become gradually more difficult to
estimate with good precision the fewer samples there are available. Moreover, MIN-
MOD is not well suited for short sampling times. In contrast, the new algorithms
included least-square regression estimation of only two parameters, CL and Vd, which
makes them less sensitive for a reduction of sampling time and/or sampling intensity.
With 12 samples, CL and Vd were estimated with the standard errors that averaged
less than 10% (data not shown).
Tura et al. [11] recently compared the ratio of the glucose disappearance rate and
AUCins with SI and Mbw in a retrospective analysis of studies comprising both volun-
teers and diabetic and postoperative patients who had undergone a frequently sampled
50-min IVGTT and a conventional 2-hour glucose clamp. Good correlations between
these indices of insulin sensitivity were claimed for all subgroups. The basic equation
used is quite similar to the one we propose on the top of Table 3. However, they did
not use the 10log of AUCins and corrected this area for the group average SI value.
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They also divided the expression by the sampling time, which we find questionable
since plasma insulin but not KG decreases with time. This fact must be handled by
using a unique equation for each sampling time, as in Tables 2 and 3.
Limitations during surgery
The present study suggests two key algorithms, together with various modifications
thereof, that may be used to estimate insulin sensitivity based on data derived from a
short IVGTT performed in healthy volunteers. In a subsequent study, these algorithms
will be validated in the pre- and postoperative settings. Our interest in this topic stems
from a wish to study insulin resistance during surgery. Virtually all non-diabetic
patients develop transient type 2 diabetes as a part of the stress response to surgery
[4,5]. Too little research has been performed to investigate the reasons and conse-
quences of this insulin resistance, which is probably due to the demanding and com-
plex nature of both the glucose clamp and the IVGTT. In this setting, it is important
that the blood sampling and the time and resources required for the test are kept low.
Moreover, the test should impose only a slight burden on the body’s physiology.
Conclusion
The ratio of the slope of the glucose elimination curve and the AUC for plasma insulin
during a short IVGTT showed a strong linear correlation (r2 = 0.63-0.83) with the
insulin sensitivity as obtained by the glucose clamp technique in healthy volunteers.
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